China-based Fosun Pharmaceuticals Ltd. is all set to acquire Hyderabad-based Gland Pharma for $1.3 billion having 96% of its stakes in the firm. The shares holding is backed by global private equity enterprise KKR & Co. The respective company deals in manufacturing of generic injectables, approved by US and UK drug regulators. The products are send in US market as …